Clinical Trial Update: Thromboprophylaxis After Surgery for Gynecologic Malignancy in China [Phase 3]

View source ↗

Summary

Phase 3 trial assessing thromboprophylaxis after gynecologic cancer surgery in China; completed study on venous thromboembolism prevention with potential LMWH/a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Neoplasms
• Venous Thromboembolism

Drugs mentioned

• Argatroban (argatroban)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Gynecologic Neoplasms, Venous Thromboembolism | Phase 3 | Status: COMPLETED